PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$1.98
-0.01 (-0.50%)
▼
5d:
+11.86%
30d:
-7.04%
90d:
-16.1%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PETS appears deeply undervalued. Market expects -47.0% annual earnings decline despite 267% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: PETS appears deeply undervalued. Market expects -47.0% annual earnings decline despite 267% recent earnings growth. Contrarian opportunity at discount to historical valuation.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $1.98, which is considered fair relative to its 30-day fair value range of $1.71 to $2.07. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.3) compared to its historical average (189.6). Remarkably, the market is currently pricing in an annual earnings decline of 47.0% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a strong downtrend. Immediate support is located at $1.62, while resistance sits at $2.27.
Market Sentiment: PETS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PETS is in a strong downtrend. Immediate support is located at $1.62, while resistance sits at $2.27.
Market Sentiment: PETS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.71 -
$2.07
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($2.15)
Trading Range Analysis
30-Day Trading Range
$1.71 -
$2.07
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.62
Resistance Level
$2.27
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.29
Wall Street Target
$2.15
(+8.6%)
Revenue Growth (YoY)
-15.6%
Earnings Growth (YoY)
266.7%
Profit Margin
-32.0%
Valuation Discount vs History
-47.0% cheaper
PE vs Historical
28.3 vs 189.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-47.0%
(market-implied from PE analysis)
1-Year Target
$1.78
(-10%)
2-Year Target
$1.60
(-19%)
3-Year Target
$1.44
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→190)
$9.68
(+389%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.3 to 189.6
Stabilization Target:
$13.27
(+570.3%)
PE Expansion Potential:
+570.3%
Share & Embed Analysis
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$6 | 60 BUY |
